You get what you pay for

35:21
 
공유
 

Manage episode 331664448 series 3291201
Player FM과 저희 커뮤니티의 CCRM 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.

How will Canada’s health care system pay for cell and gene therapy cures?
Featuring:

Dr. Chris McCabe, CEO and Executive Director, Institute of Health Economics

Robert Woolstencroft, Senior Director and Head, Market Access and Reimbursement, Gilead Sciences Canada

Our guests tackle the complex question of how therapy developers working at the cutting edge of regenerative medicine can get reimbursed when they deliver on the promise of cures. How can patients on Prince Edward Island be guaranteed equitable access to innovative new therapies compared to patients in much larger provinces like Ontario or British Columbia? Performance-based payment models are often discussed, but are they really the solution? Despite Canada’s complex and fragmented health-care system, the challenges faced are by no means insurmountable. Join us to hear how political will and partnerships across stakeholders are prerequisites for building a health-care system that’s ready to equitably deliver these innovative new therapies to patients.

6 에피소드